Found: 8
Select item for more details and to access through your institution.
Does age affect gastric emptying time? A model-based meta-analysis of data from premature neonates through to adults.
- Published in:
- Biopharmaceutics & Drug Disposition, 2015, v. 36, n. 4, p. 245, doi. 10.1002/bdd.1937
- By:
- Publication type:
- Article
First-in-human randomized study of bimekizumab, a humanized monoclonal antibody and selective dual inhibitor of IL-17A and IL-17F, in mild psoriasis.
- Published in:
- British Journal of Clinical Pharmacology, 2017, v. 83, n. 5, p. 991, doi. 10.1111/bcp.13185
- By:
- Publication type:
- Article
A generalisation of T-optimality for discriminating between competing models with an application to pharmacokinetic studies.
- Published in:
- Pharmaceutical Statistics, 2012, v. 11, n. 6, p. 503, doi. 10.1002/pst.1542
- By:
- Publication type:
- Article
Bimekizumab, a Novel Humanized IgG1 Antibody That Neutralizes Both IL-17A and IL-17F.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.01894
- By:
- Publication type:
- Article
Precision criteria to derive sample size when designing pediatric pharmacokinetic studies: Which measure of variability should be used?
- Published in:
- Journal of Clinical Pharmacology, 2014, v. 54, n. 3, p. 311, doi. 10.1002/jcph.206
- By:
- Publication type:
- Article
Reply to the editor of Journal of Pharmacokinetics and Pharmacodynamics.
- Published in:
- 2012
- By:
- Publication type:
- Letter
A reduction in between subject variability is not mandatory for selecting a new covariate.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2012, v. 39, n. 4, p. 383, doi. 10.1007/s10928-012-9256-2
- By:
- Publication type:
- Article
Population Pharmacokinetics and Exposure‐Response for Dapirolizumab Pegol From a Phase 2b Trial in Patients With Systemic Lupus Erythematosus.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 4, p. 435, doi. 10.1002/jcph.2188
- By:
- Publication type:
- Article